|
Luspatercept Clinical Trials
2 actively recruiting trials across 2 locations
Also known as: ACE-536
Los Angeles, California1 trial
A Study to Evaluate Long-term Safety in Participants Who Have Participated in Other Luspatercept (ACE-536) Clinical Trials
Childrens Hospital Los Angeles RHU
Phase 3
Tampa, Florida1 trial
Luspatercept for Anemia in Lower Risk MDS or Non-proliferative MDS/MPN Neoplasms
Moffitt Cancer Center
Phase 2
Trial data from ClinicalTrials.gov. Trial status and eligibility can change — verify directly with the study contact or on ClinicalTrials.gov.
This site does not provide medical advice. Always consult your doctor before considering enrollment in a clinical trial. Learn more on our About page.